drug protocol number
67896062CTP3001
drug sponsor
Actelion Pharmaceuticals Ltd
drug study
Macitentan (ACT-064992, Opsumit ®)
drug trial site
King Fahad Medical City (Riyadh),King Faisal Specialist Hospital and Research Center (Riyadh)
drug status
Terminated
drug phase